Amy M Denison1, Bijal D Amin2, William L Nicholson3, Christopher D Paddock1. 1. Division of High-Consequence Pathogens and Pathology, Infectious Diseases Pathology Branch. 2. Department of Pathology, Division of Surgical Pathology, Montefiore Medical Center, Bronx, New York. 3. Division of Vector-Borne Diseases, Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
BACKGROUND: Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia akari are the most common causes of spotted fever group rickettsioses indigenous to the United States. Infected patients characteristically present with a maculopapular rash, often accompanied by an inoculation eschar. Skin biopsy specimens are often obtained from these lesions for diagnostic evaluation. However, a species-specific diagnosis is achieved infrequently from pathologic specimens because immunohistochemical stains do not differentiate among the causative agents of spotted fever group rickettsiae, and existing polymerase chain reaction (PCR) assays generally target large gene segments that may be difficult or impossible to obtain from formalin-fixed tissues. METHODS: This work describes the development and evaluation of a multiplex real-time PCR assay for the detection of these 3 Rickettsia species from formalin-fixed, paraffin-embedded (FFPE) skin biopsy specimens. RESULTS: The multiplex PCR assay was specific at discriminating each species from FFPE controls of unrelated bacterial, viral, protozoan, and fungal pathogens that cause skin lesions, as well as other closely related spotted fever group Rickettsia species. CONCLUSIONS: This multiplex real-time PCR demonstrates greater sensitivity than nested PCR assays in FFPE tissues and provides an effective method to specifically identify cases of Rocky Mountain spotted fever, rickettsialpox, and R. parkeri rickettsiosis by using skin biopsy specimens. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND:Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia akari are the most common causes of spotted fever group rickettsioses indigenous to the United States. Infected patients characteristically present with a maculopapular rash, often accompanied by an inoculation eschar. Skin biopsy specimens are often obtained from these lesions for diagnostic evaluation. However, a species-specific diagnosis is achieved infrequently from pathologic specimens because immunohistochemical stains do not differentiate among the causative agents of spotted fever group rickettsiae, and existing polymerase chain reaction (PCR) assays generally target large gene segments that may be difficult or impossible to obtain from formalin-fixed tissues. METHODS: This work describes the development and evaluation of a multiplex real-time PCR assay for the detection of these 3 Rickettsia species from formalin-fixed, paraffin-embedded (FFPE) skin biopsy specimens. RESULTS: The multiplex PCR assay was specific at discriminating each species from FFPE controls of unrelated bacterial, viral, protozoan, and fungal pathogens that cause skin lesions, as well as other closely related spotted fever group Rickettsia species. CONCLUSIONS: This multiplex real-time PCR demonstrates greater sensitivity than nested PCR assays in FFPE tissues and provides an effective method to specifically identify cases of Rocky Mountain spotted fever, rickettsialpox, and R. parkeririckettsiosis by using skin biopsy specimens. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Christopher D Paddock; Richard W Finley; Cynthia S Wright; Howard N Robinson; Barbara J Schrodt; Carole C Lane; Okechukwu Ekenna; Mitchell A Blass; Cynthia L Tamminga; Christopher A Ohl; Susan L F McLellan; Jerome Goddard; Robert C Holman; John J Openshaw; John W Sumner; Sherif R Zaki; Marina E Eremeeva Journal: Clin Infect Dis Date: 2008-11-01 Impact factor: 9.079
Authors: Alice S Chapman; Johan S Bakken; Scott M Folk; Christopher D Paddock; Karen C Bloch; Allan Krusell; Daniel J Sexton; Steven C Buckingham; Gary S Marshall; Gregory A Storch; Gregory A Dasch; Jennifer H McQuiston; David L Swerdlow; Stephen J Dumler; William L Nicholson; David H Walker; Marina E Eremeeva; Christopher A Ohl Journal: MMWR Recomm Rep Date: 2006-03-31
Authors: Marc R Shapiro; Curtis L Fritz; Karen Tait; Christopher D Paddock; William L Nicholson; Kyle F Abramowicz; Sandor E Karpathy; Gregory A Dasch; John W Sumner; Patricia V Adem; Jamesina J Scott; Kerry A Padgett; Sherif R Zaki; Marina E Eremeeva Journal: Clin Infect Dis Date: 2010-02-15 Impact factor: 9.079
Authors: Jin Mei Wang; Bernard J Hudson; Matthew R Watts; Tom Karagiannis; Noel J Fisher; Catherine Anderson; Paul Roffey Journal: Emerg Infect Dis Date: 2009-06 Impact factor: 6.883
Authors: John W Sumner; Lance A Durden; Jerome Goddard; Ellen Y Stromdahl; Kerry L Clark; Will K Reeves; Christopher D Paddock Journal: Emerg Infect Dis Date: 2007-05 Impact factor: 6.883
Authors: Christopher D Paddock; Jeanine H Sanders; Amy M Denison; Atis Muehlenbachs; Sherif R Zaki Journal: J Histotechnol Date: 2016-12-12 Impact factor: 0.714
Authors: Joy A Hecht; Michelle E J Allerdice; Elizabeth A Dykstra; Laura Mastel; Rebecca J Eisen; Tammi L Johnson; Holly D Gaff; Andrea S Varela-Stokes; Jerome Goddard; Benedict B Pagac; Christopher D Paddock; Sandor E Karpathy Journal: Vector Borne Zoonotic Dis Date: 2019-04-03 Impact factor: 2.133
Authors: Yamila Romer; Santiago Nava; Francisco Govedic; Gabriel Cicuttin; Amy M Denison; Joseph Singleton; Aubree J Kelly; Cecilia Y Kato; Christopher D Paddock Journal: Am J Trop Med Hyg Date: 2014-10-27 Impact factor: 2.345
Authors: Christopher D Paddock; Michelle E J Allerdice; Sandor E Karpathy; William L Nicholson; Michael L Levin; Travis C Smith; Tom Becker; Robert J Delph; Robert N Knight; Jana M Ritter; Jeanine H Sanders; Jerome Goddard Journal: Appl Environ Microbiol Date: 2017-04-17 Impact factor: 4.792